Results 1 to 10 of about 56,461 (115)
Adoptive cell therapy for cancer treatment [PDF]
Adoptive cell therapy (ACT) is a rapidly growing anti‐cancer strategy that has shown promise in treating various cancer types. The concept of ACT involves activating patients’ own immune cells ex vivo and then transferring them back to the patients to ...
Shi Du +4 more
doaj +2 more sources
Advances in adoptive cell therapy for ovarian cancer [PDF]
Ovarian cancer remains the most lethal gynecological malignancy worldwide, with late-stage diagnosis, high recurrence rates, and chemoresistance posing persistent clinical challenges.
Na Zhao +6 more
doaj +2 more sources
Challenges and new technologies in adoptive cell therapy [PDF]
Adoptive cell therapies (ACTs) have existed for decades. From the initial infusion of tumor-infiltrating lymphocytes to the subsequent specific enhanced T cell receptor (TCR)-T and chimeric antigen receptor (CAR)-T cell therapies, many novel strategies ...
Pengchao Zhang +2 more
doaj +2 more sources
Application of adoptive cell therapy in malignant melanoma [PDF]
Cutaneous melanoma is one of the most aggressive skin cancers originating from skin pigment cells. Patients with advanced melanoma suffer a poor prognosis and generally cannot benefit well from surgical resection and chemo/target therapy due to ...
Qianrong Hu +7 more
doaj +2 more sources
Genetically Modified T Cells for Esophageal Cancer Therapy: A Promising Clinical Application
Esophageal cancer is an exceedingly aggressive and malignant cancer that imposes a substantial burden on patients and their families. It is usually treated with surgery, chemotherapy, radiotherapy, and molecular-targeted therapy. Immunotherapy is a novel
Yu-Ge Zhu +5 more
doaj +1 more source
ADOPTIVE CELL THERAPY: CURRENT ADVANCES
The immune system plays an important role in the development and treatment of many cancer types. This fact determined the emergence of numerous immunotherapeutic approaches, including that of adoptive cell therapy (ACT).
T. V. Shamova +3 more
doaj +1 more source
Background Blocking the programmed death 1 pathway by immune checkpoint inhibitors induces dramatic antitumor activity in patients with malignant tumors. However, the clinical response to immune checkpoint inhibitors remains limited owing to the patients’
Rishu Takimoto +7 more
doaj +1 more source
Optimization of culture media for ex vivo T-cell expansion for adoptive T-cell therapy
Background: Adoptive T-cell therapy is a promising treatment strategy for cancer immunotherapy. The ability of immunotherapy based on the adoptive cell transfer of genetically modified T cells to generate powerful clinical responses has been highlighted ...
Ilnaz Rahimmanesh +4 more
doaj +1 more source
Adoptive T cell therapy: Addressing challenges in cancer immunotherapy
Adoptive T cell therapy involves the ex vivo selection and expansion of effector cells for the treatment of patients with cancer. In this review, the advantages and limitations of using antigen-specific T cells are discussed in counterpoint to vaccine ...
Yee Cassian
doaj +1 more source
Adoptive cell therapy against tumor immune evasion: mechanisms, innovations, and future directions. [PDF]
Ruan L, Wang L.
europepmc +2 more sources

